##gff-version 3
##sequence-region P15941 1 1255
P15941	UniProtKB	Signal peptide	1	23	.	.	.	Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10373415,ECO:0000269|PubMed:11341784;Dbxref=PMID:10373415,PMID:11341784	
P15941	UniProtKB	Chain	24	1255	.	.	.	ID=PRO_0000019277;Note=Mucin-1	
P15941	UniProtKB	Chain	24	1097	.	.	.	ID=PRO_0000317446;Note=Mucin-1 subunit alpha	
P15941	UniProtKB	Chain	1098	1255	.	.	.	ID=PRO_0000317447;Note=Mucin-1 subunit beta	
P15941	UniProtKB	Topological domain	24	1158	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Transmembrane	1159	1181	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Topological domain	1182	1255	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Repeat	61	80	.	.	.	Note=1%3B approximate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	81	100	.	.	.	Note=2%3B approximate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	101	120	.	.	.	Note=3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	121	140	.	.	.	Note=4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	141	160	.	.	.	Note=5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	161	180	.	.	.	Note=6;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	181	200	.	.	.	Note=7;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	201	220	.	.	.	Note=8;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	221	240	.	.	.	Note=9;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	241	260	.	.	.	Note=10;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	261	280	.	.	.	Note=11;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	281	300	.	.	.	Note=12;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	301	320	.	.	.	Note=13;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	321	340	.	.	.	Note=14;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	341	360	.	.	.	Note=15;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	361	380	.	.	.	Note=16;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	381	400	.	.	.	Note=17;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	401	420	.	.	.	Note=18;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	421	440	.	.	.	Note=19;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	441	460	.	.	.	Note=20;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	461	480	.	.	.	Note=21;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	481	500	.	.	.	Note=22;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	501	520	.	.	.	Note=23;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	521	540	.	.	.	Note=24;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	541	560	.	.	.	Note=25;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	561	580	.	.	.	Note=26;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	581	600	.	.	.	Note=27;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	601	620	.	.	.	Note=28;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	621	640	.	.	.	Note=29;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	641	660	.	.	.	Note=30;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	661	680	.	.	.	Note=31;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	681	700	.	.	.	Note=32;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	701	720	.	.	.	Note=33;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	721	740	.	.	.	Note=34;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	741	760	.	.	.	Note=35;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	761	780	.	.	.	Note=36;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	781	800	.	.	.	Note=37;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	801	820	.	.	.	Note=38;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	821	840	.	.	.	Note=39;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	841	860	.	.	.	Note=40;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	861	880	.	.	.	Note=41;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	881	900	.	.	.	Note=42;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	901	920	.	.	.	Note=43;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	921	940	.	.	.	Note=44;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	941	960	.	.	.	Note=45;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	961	980	.	.	.	Note=46%3B approximate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	981	1000	.	.	.	Note=47%3B approximate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Repeat	1001	1020	.	.	.	Note=48%3B approximate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11350974;Dbxref=PMID:11350974	
P15941	UniProtKB	Domain	1039	1148	.	.	.	Note=SEA;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00188	
P15941	UniProtKB	Region	126	965	.	.	.	Note=42 X 20 AA approximate tandem repeats of P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-R	
P15941	UniProtKB	Region	1192	1228	.	.	.	Note=Interaction with P53	
P15941	UniProtKB	Region	1223	1230	.	.	.	Note=Required for interaction with GSK3B	
P15941	UniProtKB	Region	1233	1241	.	.	.	Note=Required for interaction with beta- and gamma-catenins	
P15941	UniProtKB	Motif	1203	1206	.	.	.	Note=Interaction with GRB2	
P15941	UniProtKB	Motif	1229	1232	.	.	.	Note=Interaction with SRC and ESR1	
P15941	UniProtKB	Motif	1243	1246	.	.	.	Note=Required for interaction with AP1S2	
P15941	UniProtKB	Site	1097	1098	.	.	.	Note=Cleavage%3B by autolysis	
P15941	UniProtKB	Modified residue	1203	1203	.	.	.	Note=Phosphotyrosine%3B by PDGFR;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14521915,ECO:0000269|PubMed:17545600;Dbxref=PMID:14521915,PMID:17545600	
P15941	UniProtKB	Modified residue	1212	1212	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14521915;Dbxref=PMID:14521915	
P15941	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphotyrosine%3B by PDGFR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17545600;Dbxref=PMID:17545600	
P15941	UniProtKB	Modified residue	1224	1224	.	.	.	Note=Phosphothreonine%3B by PKC/PRKCD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11877440;Dbxref=PMID:11877440	
P15941	UniProtKB	Modified residue	1227	1227	.	.	.	Note=Phosphoserine%3B by GSK3-beta;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:9819408;Dbxref=PMID:23186163,PMID:9819408	
P15941	UniProtKB	Modified residue	1229	1229	.	.	.	Note=Phosphotyrosine%3B by CSK%2C EGFR and SRC;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11152665,ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:14521915,ECO:0000269|PubMed:17545600;Dbxref=PMID:11152665,PMID:11483589,PMID:14521915,PMID:17545600	
P15941	UniProtKB	Modified residue	1243	1243	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14521915;Dbxref=PMID:14521915	
P15941	UniProtKB	Lipidation	1184	1184	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16507569;Dbxref=PMID:16507569	
P15941	UniProtKB	Lipidation	1186	1186	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16507569;Dbxref=PMID:16507569	
P15941	UniProtKB	Glycosylation	131	131	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000305,ECO:0000305;evidence=ECO:0000305|PubMed:7744025,ECO:0000305|PubMed:9597769;Dbxref=PMID:7744025,PMID:9597769	
P15941	UniProtKB	Glycosylation	139	139	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000305,ECO:0000305;evidence=ECO:0000305|PubMed:7744025,ECO:0000305|PubMed:9597769;Dbxref=PMID:7744025,PMID:9597769	
P15941	UniProtKB	Glycosylation	140	140	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Glycosylation	144	144	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Glycosylation	957	957	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Glycosylation	975	975	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Glycosylation	1029	1029	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Glycosylation	1055	1055	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Glycosylation	1133	1133	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P15941	UniProtKB	Alternative sequence	19	21	.	.	.	ID=VSP_003281;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.25	
P15941	UniProtKB	Alternative sequence	19	19	.	.	.	ID=VSP_003280;Note=In isoform 2%2C isoform Y-LSP%2C isoform E2%2C isoform J13%2C isoform S2 and isoform T10. T->TATTAPKPAT;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:22941036,ECO:0000303|PubMed:2318825,ECO:0000303|PubMed:2597151,ECO:0000303|PubMed:8608966,ECO:0000303|Ref.15;Dbxref=PMID:15489334,PMID:22941036,PMID:2318825,PMID:2597151,PMID:8608966	
P15941	UniProtKB	Alternative sequence	20	31	.	.	.	ID=VSP_003282;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.25	
P15941	UniProtKB	Alternative sequence	54	1151	.	.	.	ID=VSP_047872;Note=In isoform E2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22941036;Dbxref=PMID:22941036	
P15941	UniProtKB	Alternative sequence	54	1093	.	.	.	ID=VSP_047873;Note=In isoform T10. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22941036;Dbxref=PMID:22941036	
P15941	UniProtKB	Alternative sequence	54	1053	.	.	.	ID=VSP_003285;Note=In isoform J13%2C isoform Y%2C isoform Y-LSP and isoform S2. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:15969018,ECO:0000303|PubMed:22941036,ECO:0000303|PubMed:7925397,ECO:0000303|PubMed:9212228,ECO:0000303|Ref.15;Dbxref=PMID:15489334,PMID:15969018,PMID:22941036,PMID:7925397,PMID:9212228	
P15941	UniProtKB	Alternative sequence	54	1035	.	.	.	ID=VSP_003286;Note=In isoform 8%2C isoform 9 and isoform M6. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:22941036,ECO:0000303|PubMed:9212228,ECO:0000303|Ref.12,ECO:0000303|Ref.16;Dbxref=PMID:22941036,PMID:9212228	
P15941	UniProtKB	Alternative sequence	54	96	.	.	.	ID=VSP_047575;Note=In isoform ZD. VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPASGSAATWGQ->IPAPTTTKSCRETFLKCFCRFINKGVFWASPILSSGQDLWWYN;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15623537,ECO:0000303|PubMed:22941036;Dbxref=PMID:15623537,PMID:22941036	
P15941	UniProtKB	Alternative sequence	54	87	.	.	.	ID=VSP_035046;Note=In isoform F. VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPA->IPAPTTTKSCRETFLKCFCRFINKGVFWASPILS;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.14	
P15941	UniProtKB	Alternative sequence	54	70	.	.	.	ID=VSP_003283;Note=In isoform 6. VSMTSSVLSSHSPGSGS->IPAPTTTKSCRETFLKW;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:22941036,ECO:0000303|PubMed:9212228;Dbxref=PMID:22941036,PMID:9212228	
P15941	UniProtKB	Alternative sequence	71	1095	.	.	.	ID=VSP_003284;Note=In isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:22941036,ECO:0000303|PubMed:9212228;Dbxref=PMID:22941036,PMID:9212228	
P15941	UniProtKB	Alternative sequence	88	1139	.	.	.	ID=VSP_035047;Note=In isoform F. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.14	
P15941	UniProtKB	Alternative sequence	97	1255	.	.	.	ID=VSP_047576;Note=In isoform ZD. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15623537,ECO:0000303|PubMed:22941036;Dbxref=PMID:15623537,PMID:22941036	
P15941	UniProtKB	Alternative sequence	1077	1181	.	.	.	ID=VSP_003287;Note=In isoform 9 and isoform S2. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:22941036,ECO:0000303|Ref.12,ECO:0000303|Ref.15;Dbxref=PMID:22941036	
P15941	UniProtKB	Alternative sequence	1077	1087	.	.	.	ID=VSP_003288;Note=In isoform 5. FLQIYKQGGFL->VSIGLSFPMLP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:2351132;Dbxref=PMID:2351132	
P15941	UniProtKB	Alternative sequence	1088	1255	.	.	.	ID=VSP_003289;Note=In isoform 5. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:2351132;Dbxref=PMID:2351132	
P15941	UniProtKB	Alternative sequence	1141	1180	.	.	.	ID=VSP_046962;Note=In isoform M6. VSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIA->GCLSVPPKELRAAGHLSSPGYLPSYERVPHLPHPWALCAP;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:22941036,ECO:0000303|Ref.16;Dbxref=PMID:22941036	
P15941	UniProtKB	Alternative sequence	1181	1255	.	.	.	ID=VSP_046963;Note=In isoform M6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:22941036,ECO:0000303|Ref.16;Dbxref=PMID:22941036	
P15941	UniProtKB	Alternative sequence	1232	1255	.	.	.	ID=VSP_047874;Note=In isoform J13. VSAGNGGSSLSYTNPAVAATSANL->RQNGWSTMPRGALPEESQG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22941036;Dbxref=PMID:22941036	
P15941	UniProtKB	Natural variant	1117	1117	.	.	.	ID=VAR_019390;Note=V->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15969018,ECO:0000269|PubMed:22941036,ECO:0000269|Ref.17;Dbxref=dbSNP:rs1611770,PMID:15969018,PMID:22941036	
P15941	UniProtKB	Natural variant	1142	1142	.	.	.	ID=VAR_019391;Note=S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.17;Dbxref=dbSNP:rs11465207	
P15941	UniProtKB	Mutagenesis	1098	1098	.	.	.	Note=Completely abrogates cleavage. S->A%2CD%2CE%2CF%2CG%2CH%2CI%2CK%2CL%2CM%2CN%2CP%2CQ%2CR%2CV%2CW%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15987679;Dbxref=PMID:15987679	
P15941	UniProtKB	Mutagenesis	1098	1098	.	.	.	Note=Almost complete cleavage. S->C%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15987679;Dbxref=PMID:15987679	
P15941	UniProtKB	Mutagenesis	1116	1116	.	.	.	Note=Greatly reduced formation of isoform 5/isoform Y complex. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10197628;Dbxref=PMID:10197628	
P15941	UniProtKB	Mutagenesis	1116	1116	.	.	.	Note=No effect on formation of isoform 5/isoform Y complex. D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10197628;Dbxref=PMID:10197628	
P15941	UniProtKB	Mutagenesis	1184	1184	.	.	.	Note=S-palmitoylation reduced by 50%25. Complete loss of palmitoylation%2C no effect on endocytosis%2C recycling inhibited and AP1S1 binding reduced by 30%25%3B when associated with C-1186. Accumulates in intracellular compartments%3B when associated with C-1186 and N-1203. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16507569;Dbxref=PMID:16507569	
P15941	UniProtKB	Mutagenesis	1186	1186	.	.	.	Note=S-palmitoylation reduced by 50%25. Complete loss of palmitoylation%2C no effect on endocytosis%2C recycling inhibited%2C and AP1S1 binding reduced by 30%25%3B when associated with C-1184. Accumulates in intracellular compartments%3B when associated with C-1184 and N-1203. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16507569;Dbxref=PMID:16507569	
P15941	UniProtKB	Mutagenesis	1187	1189	.	.	.	Note=No nuclear targeting of HRG-stimulated MUC1 C-terminal nor JUP/gamma-catenin. No effect on interaction with JUP/gamma-catenin. RRK->AAA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12939402,ECO:0000269|PubMed:16507569;Dbxref=PMID:12939402,PMID:16507569	
P15941	UniProtKB	Mutagenesis	1187	1189	.	.	.	Note=No effect on palmitoylation. RRK->QQQ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12939402,ECO:0000269|PubMed:16507569;Dbxref=PMID:12939402,PMID:16507569	
P15941	UniProtKB	Mutagenesis	1191	1191	.	.	.	Note=No effect on EGFR-mediated phosphorylation. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:15471854;Dbxref=PMID:11483589,PMID:15471854	
P15941	UniProtKB	Mutagenesis	1191	1191	.	.	.	Note=No effect on endocytosis. Y->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:15471854;Dbxref=PMID:11483589,PMID:15471854	
P15941	UniProtKB	Mutagenesis	1203	1203	.	.	.	Note=No effect on nuclear colocalization of MUC1CT and CTNNB1. No effect on in vitro PDFGR-induced cell invasiveness. Y->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:15471854,ECO:0000269|PubMed:16507569,ECO:0000269|PubMed:17545600;Dbxref=PMID:11483589,PMID:15471854,PMID:16507569,PMID:17545600	
P15941	UniProtKB	Mutagenesis	1203	1203	.	.	.	Note=No effect on EGFR-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-induced cell invasiveness. Y->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:15471854,ECO:0000269|PubMed:16507569,ECO:0000269|PubMed:17545600;Dbxref=PMID:11483589,PMID:15471854,PMID:16507569,PMID:17545600	
P15941	UniProtKB	Mutagenesis	1203	1203	.	.	.	Note=Reduced endocytosis by 30%25. Greatly reduced binding to AP1S2 and GRB2. Binding AP1S1 reduced by 25%25. Reduced endocytosis by 77%25%3B when associated with N-1243. Accumulates in intracellular compartments%3B when associated with C-1184 and C-1186. Y->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:15471854,ECO:0000269|PubMed:16507569,ECO:0000269|PubMed:17545600;Dbxref=PMID:11483589,PMID:15471854,PMID:16507569,PMID:17545600	
P15941	UniProtKB	Mutagenesis	1209	1209	.	.	.	Note=Some reduction in EGFR-mediated phosphorylation. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11483589;Dbxref=PMID:11483589	
P15941	UniProtKB	Mutagenesis	1218	1218	.	.	.	Note=No effect on EGFR-mediated phosphorylation. No nuclear colocalization of MUC1CT and CTNNB1. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:17545600;Dbxref=PMID:11483589,PMID:17545600	
P15941	UniProtKB	Mutagenesis	1223	1223	.	.	.	Note=No change in PRKCD- nor GSK3B-mediated phosphorylation. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11877440,ECO:0000269|PubMed:9819408;Dbxref=PMID:11877440,PMID:9819408	
P15941	UniProtKB	Mutagenesis	1224	1224	.	.	.	Note=Loss of PRKCD-mediated phosphorylation. Decreased PRKCD binding. No increased binding to CTNNB1 in the presence of autophosphorylated PRKCD. Increases formation of E-cadherin/beta-catenin complex. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11877440;Dbxref=PMID:11877440	
P15941	UniProtKB	Mutagenesis	1227	1227	.	.	.	Note=No change in PRKCD-mediated phosphorylation. Loss of GSK3B-mediated phosphorylation. CTNNB1. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11877440,ECO:0000269|PubMed:9819408;Dbxref=PMID:11877440,PMID:9819408	
P15941	UniProtKB	Mutagenesis	1229	1229	.	.	.	Note=Greatly reduced EGFR- and Src-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-mediated phosphorylation. Decreased Src-binding. Y->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11152665,ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:14688481,ECO:0000269|PubMed:15471854;Dbxref=PMID:11152665,PMID:11483589,PMID:14688481,PMID:15471854	
P15941	UniProtKB	Mutagenesis	1229	1229	.	.	.	Note=No effect on endocytosis. Y->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11152665,ECO:0000269|PubMed:11483589,ECO:0000269|PubMed:14688481,ECO:0000269|PubMed:15471854;Dbxref=PMID:11152665,PMID:11483589,PMID:14688481,PMID:15471854	
P15941	UniProtKB	Mutagenesis	1243	1243	.	.	.	Note=Reduces binding to AP1S2 by 33%25. Greatly reduced binding to GRB2. Reduced endocytosis by 50%25. Reduced endocytosis by 77%25%3B when associated with N-1203. Y->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15471854;Dbxref=PMID:15471854	
P15941	UniProtKB	Sequence conflict	2	2	.	.	.	Note=T->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	134	134	.	.	.	Note=P->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	154	154	.	.	.	Note=P->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	1021	1021	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	1021	1021	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	1021	1021	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	1143	1143	.	.	.	Note=D->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	1193	1193	.	.	.	Note=Q->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	1231	1231	.	.	.	Note=K->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Sequence conflict	1251	1251	.	.	.	Note=T->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15941	UniProtKB	Beta strand	1042	1052	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Helix	1056	1059	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Helix	1064	1080	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Turn	1082	1085	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Beta strand	1086	1096	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Beta strand	1099	1107	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Turn	1109	1111	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Helix	1114	1132	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
P15941	UniProtKB	Beta strand	1136	1142	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ACM	
